Perspective Therapeutics, Inc. (CATX)
0.78
-0.08
(-9.29%)
USD |
NYAM |
Nov 18, 16:00
0.7902
+0.01
(+1.31%)
After-Hours: 20:00
Perspective Therapeutics EPS Diluted (Quarterly) : -0.2687 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.2687 |
| June 30, 2026 | -0.222 |
| March 31, 2026 | -0.2528 |
| December 31, 2025 | -0.5043 |
| September 30, 2025 | -0.3495 |
| June 30, 2025 | -0.2894 |
| March 31, 2025 | -0.2512 |
| December 31, 2024 | -0.5684 |
| September 30, 2024 | -0.2141 |
| June 30, 2024 | -0.1756 |
| March 31, 2024 | -0.2481 |
| September 30, 2023 | -0.3691 |
| June 30, 2023 | -0.3967 |
| March 31, 2023 | -0.0162 |
| June 30, 2022 | -0.1463 |
| March 31, 2022 | -0.0948 |
| December 31, 2021 | -0.113 |
| September 30, 2021 | -0.1581 |
| June 30, 2021 | -0.0749 |
| March 31, 2021 | -0.0608 |
| December 31, 2020 | -0.1045 |
| September 30, 2020 | -0.1039 |
| June 30, 2020 | -0.175 |
| March 31, 2020 | -0.0811 |
| December 31, 2019 | -0.1334 |
| Date | Value |
|---|---|
| September 30, 2019 | -0.1215 |
| June 30, 2019 | -0.163 |
| March 31, 2019 | -0.1678 |
| December 31, 2018 | -0.2103 |
| September 30, 2018 | -0.2284 |
| June 30, 2018 | -0.40 |
| March 31, 2018 | -0.20 |
| December 31, 2017 | -0.30 |
| September 30, 2017 | -0.30 |
| June 30, 2017 | -0.30 |
| March 31, 2017 | -0.20 |
| December 31, 2016 | -0.30 |
| September 30, 2016 | -0.30 |
| June 30, 2016 | -0.20 |
| March 31, 2016 | -0.20 |
| December 31, 2015 | -0.20 |
| September 30, 2015 | -0.20 |
| June 30, 2015 | -0.20 |
| March 31, 2015 | -0.20 |
| December 31, 2014 | -0.20 |
| September 30, 2014 | -0.10 |
| June 30, 2014 | -0.3072 |
| March 31, 2014 | -0.50 |
| December 31, 2013 | -0.20 |
| September 30, 2013 | -0.60 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.0232 |
| MiMedx Group, Inc. | -0.0595 |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | 0.0431 |
| Enovis Corp. | 0.0537 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.44M |
| Revenue (Quarterly) | 0.02M |
| Total Expenses (Quarterly) | 32.46M |
| Enterprise Value | -99.85M |
| Gross Profit Margin (Quarterly) | -5.86K% |
| Profit Margin (Quarterly) | -162.2K% |
| Earnings Yield | -160.0% |
| Normalized Earnings Yield | -147.90 |